Fang Ming

Senior Director, Global Business Development, S&E at GSK

Speaker

Dr. Ming Fang is Senior Director, Business Development at GSK, responsible for exploring licensing and M&A opportunities in the Chinese market. Before GSK, she served as Director of Global Business Development & Licensing at Merck Healthcare KGaA, spearheading access to external innovation and fostering collaborations with biopharma/biotech companies in China and the APAC region. Ming has led several licensing partnerships and multiple research and clinical collaborations with local innovators.

Prior to joining Merck, Ming served as the Head of Business Development at Elpiscience Biopharma, leading business development and strategy efforts. In this role, she led the closure of significant licensing deals and collaborations. She also held positions at Zailab and Novartis, focusing on external collaboration and oncology R&D.

Ming completed her Ph.D. training at the Curie Institute in Paris and holds both Ph.D. and Master's degrees in Cancer Biology and Genetics with honors from Université Pierre et Marie Curie in Paris, France.